The New England Journal of Medicine , Volume 387, pp 2101-2103; https://doi.org/10.1056/nejmc2212742
Abstract:To the Editor: With respect to the review article on chronic urticaria by Lang (Sept. 1 issue),1 angioedema may be of special interest. Bradykinin-mediated angioedema was not addressed in the review. This rare chronic hereditary urticaria mediated by bradykinin may be life-threatening, and treatments for this condition have been developed.2 Clinicians may also see angiotensin-converting–enzyme (ACE) inhibitor–induced angioedema that does not respond to treatment with antihistamines and glucocorticoids. To the Editor: In the review article on chronic urticaria, Figure 3 describes stepped care. The author states that the information in this figure was synthesized from recommendations based on clinical guidelines. . . .
Keywords: treatment / Editor / Bradykinin / figure / review article on chronic urticaria
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Click here to see the statistics on "The New England Journal of Medicine" .